Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

The Clinical Flexible Analyzer- a new generation IVD testing device aimed to increase the competitiveness of local healthcare vs. large laboratories

Project description

A cost-effective all-in-one diagnostic analyser

In vitro diagnostics is a large field that focuses on the analysis of vital parameters in various samples (blood, urine, saliva) that enable clinicians to reach diagnosis. Recent advances in technology and automation have led to the development of large workstation-based analysers capable of carrying out multi-parameter analysis in a single device. However, these are pricey, and small diagnostic centres or clinics cannot afford them. To address this problem, the EU-funded CFA project has developed an automated, all-in-one, cost-effective analyser that can perform biochemical and immunological techniques in the same device. The device is expected to improve the services in a local setting and increase their competitiveness.

Objective

Increasing population and rise in chronic diseases have led to an enormous demand for faster and better in-vitro diagnostic tests of parameters for improved detection and cure of diseases. However, there is significant fragmentation and separation in the IVD immunochemical analyzers market, depending on the end users’ size: on one hand there are large workstations (analyzers) capable of analyzing several parameters in one device, which are extremely large and pricey, and on the other hand, there are stand-alone devices with much narrower parameter testing, low throughput and efficiency, which are mainly based on 30 years old technology. These latter are the only option for smaller local clinics, which cannot afford the large, combined workstations, and thus, lose competitiveness to large laboratories who can afford them.
Our company, MEON Medical Solutions, is an Austrian based SME specialized in developing IVD medical devices for measurement of vital parameters to support medical professionals in clinical diagnostics. Our over 30 years of experience in the field enabled us to identify the business opportunity derived from the needs of small clinics and laboratories, for which we have developed the CFA – Clinical Flexible Analyzer- i.e. an innovative, automated, all-in-one immunochemical analyzer that combines the three most demanded diagnostic methods - Clinical Chemistry, Heterogeneous Immunoassays and Ion Selective Electrodes - in a single small modular, highly flexible and cost-efficient device. The CFA will enable small laboratories to provide an extremely cost-efficient local healthcare, and boost the growth of our company: We have estimated that after 5 years of CFA’s commercial launch in 2022, we will have engaged into 1,000 small clinics and hospitals globally, boosting the economic growth of our company, and enabling us to achieve a leading position over all other competitors.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

MEON MEDICAL SOLUTIONS GMBH & CO KG
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
NEUE STIFTINGTALSTRASSE 2
8010 Graz
Austria

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Südösterreich Steiermark Graz
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0